(Video)Coronavirus Vaccine; Moderna biotech, US Clinical Virology tests first Anti-Coronavirus vaccine

COVID-19 coronavirus laboratory in Shenyang in China's northeastern Liaoning. PHOTO | NYT

A United States laboratory is said to be testing a corona Anti-Virus vaccine.  The lab is said to be in its final stages in testing the Anti-Virus vaccine. It will be available in the next few days.


Dr Alex Greninger, an assistant professor in the Department of Laboratory Medicine and an assistant director of the Clinical Virology Laboratory at the University of Washington Medical Center says US labs are in better step for creating a cure and vaccine for the coronavirus.


In partnership with COVID-19 coronavirus laboratory in Shenyang in China's northeastern Liaoning, Clinical Virology laboratory and the San Diego lab, Moderna Biotech lab in the US have come up with a mild coronavirus vaccine(mRNA-1273).


Dr Alex Greninger says in a few days, countries that are prone to the virus will have a positive move to contain the virus.

Coronavirus vaccine in out#CoronaVirusUpdate #Ruto #Somalia pic.twitter.com/44CIeTcY3p

— george rama (@george_rama) March 2, 2020

" We are making efforts to avail the first-ever anti-corona virus vaccine in a few days. We are now testing to find out how effective it is to the people. We tested it with domestic animals and it was effective, " a Clinical virology lab official said.



Kenneth E. Raske, president of the Greater New York Hospital Association, said,  he planned to appeal to Vice President Mike Pence whom President Trump named to lead federal preparations “to order the C.D.C. to develop a coronavirus rapid point of care test” that hospitals could use to screen patients.



 US biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunization.



 Initial trials of the potential vaccine could begin in April, but the process of testing and approvals would last at least a year. Moderna (MRNA) said in a statement Monday that the first batch of its novel coronavirus vaccine, called mRNA-1273, has been sent to the National Institute of Allergy and Infectious Diseases (NIAID)